Galapagos signs new compound management agreement
Galapagos NV announces that its service division BioFocus DPI will provide compound management and related services to Sepracor Inc. Total contract value for Galapagos is EUR1 million. Under the terms of the agreement, BioFocus DPI will receive, register, and store selected compounds from Sepracor's proprietary compound library, and plate and replicate these compounds for a period of three years. Services will be provided by BioFocus DPI's compound management facility in South San Francisco, USA.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Abbott to Acquire Veropharm

Anti-counterfeiting fluorescent marker developed - Sweet code with laser printing
Centre_for_Infectious_Disease_Research_in_Zambia_(CIDRZ)
BRAIN announces €60m round of financing to expand its buy-and-build strategy

Bioprinting of Highly Complex Structures Now Possible - Cooperation of UpNano and BIO INX yields further advancement: Two-stage 3D-printing of organ-on-chip devices with encapsulated live cells is possible
Bicalutamide
